Speaker illustration

Doctor Michael Maeng

Aarhus University Hospital, Aarhus (Denmark)

Member of:

EAPCI

Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)

Event: ESC Congress 2018

Topic: Percutaneous Coronary Intervention (PCI) and Surgery

Session: Best Posters in preventive cardiology

Thumbnail

Optimal timing of complete revascularisation in N-STEMI.

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: Coronary intervention for ischaemic heart disease

Thumbnail

5-year clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: A pooled analysis of SORT OUT III, IV, and V studies.

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: Targeting very late restenosis

Thumbnail

Long term outcomes of first and second generation drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from SORT OUT III, IV and V trials.

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: Long-term outcome of coronary stents and scaffolds

Thumbnail

Rate of very late stent thrombosis differs between drug-eluting stents: a 5-year pooled landmark analysis of the SORT OUT III, IV, and V trials

Event: ESC CONGRESS 2017

Topic: PCI / stents: devices and technique

Session: Optimised myocardial revascularisation strategies

Thumbnail

Landmark analysis of clinical outcome following first-generation vs newer-generation coronary drug-eluting stent implantation: A pooled analysis of SORT OUT III-V studies

Event: ESC CONGRESS 2017

Topic: PCI: long-term outcome

Session: Long-Term outcomes of PCI

Thumbnail

This platform is supported by

logo Novo Nordisk